(Q43816395)

English

Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement

scientific article published on 16 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Mhm Ezzat

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Tma El-Gammasy

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kya Shaheen

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Esm Shokr

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

16 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

845-854

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Expression of functional CCR and CXCR chemokine receptors in podocytes

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Chemokine requirements for B cell entry to lymph nodes and Peyer's patches.

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII)

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Prospective study of serum and urinary nitrate levels in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Intrafollicular location of marginal zone/CD1d(hi) B cells is associated with autoimmune pathology in a mouse model of lupus

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Aberrant B1 cell trafficking in a murine model for lupus

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

The chemokine network in systemic lupus erythematous nephritis

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

B lymphocytes and lupus nephritis: new insights into pathogenesis and targeted therapies

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Dehydroepiandrosterone in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Anti-DNA antibodies in the pathogenesis of lupus nephritis--the emerging mechanisms

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Green tea and prostate cancer: from bench to clinic

1 reference

https://api.crossref.org/works/10.1177%2F0961203311398513

21 January 2018

Identifiers

10.1177/0961203311398513

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43816395&oldid=2103600951"